These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12810630)

  • 1. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
    Liu LT; Chang HC; Chiang LC; Hung WC
    Cancer Res; 2003 Jun; 63(12):3069-72. PubMed ID: 12810630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.
    Liu LT; Chang HC; Chiang LC; Hung WC
    Oncogene; 2002 Nov; 21(54):8347-50. PubMed ID: 12447698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
    Kang HG; Kim HS; Kim KJ; Oh JH; Lee MR; Seol SM; Han I
    J Orthop Res; 2007 May; 25(5):696-702. PubMed ID: 17262820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression.
    Jeon HW; Lee YM
    Mol Cancer Ther; 2010 May; 9(5):1361-70. PubMed ID: 20442303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
    Choi YH
    Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.
    Chang HC; Cho CY; Hung WC
    Cancer Res; 2006 Sep; 66(17):8413-20. PubMed ID: 16951151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines.
    Simizu S; Takagi S; Tamura Y; Osada H
    Cancer Res; 2005 Aug; 65(16):7455-61. PubMed ID: 16103099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
    Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyl CpG-binding domain protein 3 mediates cancer-selective cytotoxicity by histone deacetylase inhibitors via differential transcriptional reprogramming in lung cancer cells.
    Noh EJ; Jang ER; Jeong G; Lee YM; Min CK; Lee JS
    Cancer Res; 2005 Dec; 65(24):11400-10. PubMed ID: 16357148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H; Wu X
    Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RECK negatively regulates matrix metalloproteinase-9 transcription.
    Takagi S; Simizu S; Osada H
    Cancer Res; 2009 Feb; 69(4):1502-8. PubMed ID: 19208844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
    Vinodhkumar R; Song YS; Ravikumar V; Ramakrishnan G; Devaki T
    Chem Biol Interact; 2007 Feb; 165(3):220-9. PubMed ID: 17240363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
    Takemoto N; Tada M; Hida Y; Asano T; Cheng S; Kuramae T; Hamada J; Miyamoto M; Kondo S; Moriuchi T
    Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
    Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
    J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RECK is a target of Epstein-Barr virus latent membrane protein 1.
    Liu LT; Peng JP; Chang HC; Hung WC
    Oncogene; 2003 Nov; 22(51):8263-70. PubMed ID: 14614450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
    Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells.
    Cho CY; Wang JH; Chang HC; Chang CK; Hung WC
    J Cell Physiol; 2007 Oct; 213(1):65-9. PubMed ID: 17443689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing.
    Ahn MY; Kang DO; Na YJ; Yoon S; Choi WS; Kang KW; Chung HY; Jung JH; Min do S; Kim HS
    Cancer Lett; 2012 Dec; 325(2):189-99. PubMed ID: 22781396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.